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ABSTRACT
BACKGROUND AND PURPOSE: 4D CT angiography is increasingly used in clinical practice for the assessment of different neurovascular
disorders. Optimized processing of 4D-CTA is crucial for diagnostic interpretation because of the large amount of data that is generated.
A color-mapping method for 4D-CTA is presented for improved and enhanced visualization of the cerebral vasculature hemodynamics.
This method was applied to detect cranial AVFs.
MATERIALSANDMETHODS: All patients who underwent both 4D-CTA andDSA in our hospital from 2011 to 2018 for the clinical suspicion
of a cranial AVF or carotid cavernous fistula were retrospectively collected. Temporal information in the cerebral vasculature was
visualized using a patient-specific color scale. All color-maps were evaluated by 3 observers for the presence or absence of an AVF or
carotid cavernous fistula. The presence or absence of cortical venous reflux was evaluated as a secondary outcome measure.
RESULTS: In total, 31 patients were included, 21 patients with and 10 without an AVF. Arterialization of venous structures in AVFs was
accurately visualized using color-mapping. There was high sensitivity (86%–100%) and moderate-to-high specificity (70%–100%) for the
detection of AVFs on color-mapping 4D-CTA, evenwithout the availability of dynamic subtraction rendering. The diagnostic performance
of the 3 observers in the detection of cortical venous reflux was variable (sensitivity, 43%–88%; specificity, 60%–80%).
CONCLUSIONS: Arterialization of venous structures can be visualized using color-mapping of 4D-CTA and proves to be accurate for the
detection of cranial AVFs. This finding makes color-mapping a promising visualization technique for assessing temporal hemodynamics in
4D-CTA.
ABBREVIATIONS: CCF carotid cavernous fistula; TTS time-to-signal
Four-dimensional CT angiography (4D-CTA) is increasinglyused in clinical practice for the assessment of different neuro-
vascular disorders as a noninvasive alternative to invasive DSA.1
Multiple acquisitions over time enable visualization of the cere-
bral vasculature hemodynamics. Dynamic acquisition during the
passage of a contrast bolus enables accurate detection of arterial-
venous shunting, seen as abnormal early contrast enhancement of
a dural sinus or cortical vein, due to an AVMor AVF.2-5 Themain
arterial feeders of AVFs can be identified, and the pathway of
venous drainage can be estimated. Compared withDSA, 4D-CTA
is less time-consuming, less expensive, and has a lower risk of
complications.6,7 In addition, 4D-CTA is less sensitive to the tim-
ing of the acquisition relative to the contrast bolus injection as
opposed to static, single-phase CTA.
The high spatial and temporal resolution of 4D-CTA yields
large amounts of data, resulting in a laborious and time-consum-
ing diagnostic evaluation and hampers direct interpretation, even
for experienced observers. The challenge of 4D-CTA lies in com-
prehensively and accurately visualizing the essential parts of the
imaging data. For example, in the diagnostic work-up of cranial
arteriovenous shunts, a continuous 4D-CTA acquisition with
high temporal and spatial resolution is crucial, and hemody-
namics is evaluated by creating dynamic CTA subtraction im-
ages. The evaluation of dynamic CTA requires an accurate
evaluation of multiple individual time points for the detection
of arterialized venous structures. In a more sophisticated ap-
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proach for evaluating the vascular morphology on 4D-CTA,
the whole 4D dataset can be condensed into a 3D dataset using
a temporal maximum intensity projection.8 However, this pro-
jection has the disadvantage of temporal information being
lost.
In this work, a visualization technique for 4D-CTA is pro-
posed that is based onmapping the contrast bolus arrival times in
the cerebral vasculature to a color scale. A flowwindow is adjusted
specifically for each patient on the basis of the aggregated tempo-
ral information. The method retains temporal (4D) information
in a 3D reconstruction. The 4D-CTA color-mappingmethod was
evaluated in an observer study for the detection of cranial AVFs.
MATERIALS AND METHODS
Study Design and Study Population
All patients older than 18 years of age who underwent both 4D-
CTA andDSA in our hospital (RadboudUniversityMedical Hos-
pital, Nijmegen) from 2011 to 2018 for the clinical suspicion of a
cranial AVF or carotid cavernous fistula (CCF) were retrospec-
tively collected. Patients with a proved AVM (ie, the presence of
an intervening nidus) were excluded. The study was approved by
themedical ethical committee of our hospital, and informed con-
sent was waived because of the retrospective collection of the
study data. The study was conducted in accordance with the eth-
ical standards of the 1964 Declaration of Helsinki and its later
amendments.
Data Acquisition
All patients underwent whole-brain 4D-CTA on a 320–detector-
row Aquilion ONE CT scanner (Canon Medical Systems, Tokyo,
Japan). The 4D-CTA scanning protocol consisted of a 10- to 12-
second continuous acquisition (80 kV, 115 mAs, 0.5-second ro-
tation speed) reconstructed at a temporal resolution of 1 volume
per second. A 50-mL contrast agent bolus of iomeprol (300 mg
iodine/mL, Iomeron; Bracco, Milan, Italy) was intravenously in-
jected. A test bolus of 15 mL of contrast agent was used for the
timing of the acquisition. Image reconstruction was performed
with a smooth reconstruction kernel (FC41), resulting in an im-
agematrix of 512 512 with voxel sizes of 0.43 0.43 0.5mm.
The estimatedmean radiation dose for the 4D-CTA examinations
was 6.6 mSv (dose-length product, 3176; k-factor, 0.0021).
Color-Mapping
The color-mapping visualization of 4D-CTA consists of 4 steps
(Fig 1). First, the vessels are segmented using a random forest
classifier using a weighted temporal average and variance as the
main image features.9 The second step is calculation of the con-
trast bolus arrival times in the segmented vessels. Gaussian blur-
ring is applied in the temporal direction with   3 seconds to
reduce noise while maintaining spatial resolution. The tissue at-
tenuation curve per voxel describes contrast changes over time in
Hounsfield units (HU). For each vessel voxel, a point on this
curve is searched where the attenuation reaches a fraction, , of
the maximum signal intensity, corrected for the baseline
intensity:
1) IThreshold Imin   Imax Imin.
Here, Imin and Imax are the minimum and maximum intensity in
the temporal direction for the current voxel. Depending on the
application,  may range from 0 to 1, where 1 resulted in the
FIG 1. Overview of the proposed method. First, the vessels are segmented in the 4D-CTA acquisitions. Second, time-to-signal is calculated per
vessel voxel in the segmentation. Third, the TTS values are aggregated in a histogram, and the start and end of the flowwindow are determined.
Last, a color scale is mapped to the flow window, and the colors are overlaid on the vessel segmentation.
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temporalmaximum intensity projection and the time-to-peak. In
our method, the parameter, , was set to 0.2 for optimal evalua-
tion of contrast bolus arrival times. The TTS is linearly interpo-
lated using IThreshold and the known acquisition time points as
follows:
2) TTS  T0    T1  T0,
With
3)  
IThreshold I0
I1  I0
.
Here,T0,T1, I0, and I1 are the acquisition time points and intensity
values around IThreshold, respectively, as shown in the profile in-
tensity curve plot in Fig 1. In the next step, all TTS values of the
vessels are aggregated in a histogram that is used to determine a
flow window for each patient specifically. The start and end of the
flowwindow are defined as the first and last time points that reach
20% of the maximum peak in the histogram, as illustrated by the
TTS histogram in Fig 1. In the final step of the method, a color
scale is adjusted around the flow window and overlaid on the
vessel segmentation to visualize the arrival times and thus the flow
dynamics in the cerebral vasculature.
Diagnostic Evaluation
Three observers, 2 neuroradiologists (F.J.A.M., S.A.H.P.) and a
neurosurgeon (H.D.B.) with various levels of experience in read-
ing 4D-CTA, evaluated the color-mapping visualization datasets.
The cases were presented to the observers in a random order, and
the observers were blinded to clinical symptoms, DSA, and pa-
tient outcome. Initially, only color-mapping processing of 4D-
CTAas an overlay on temporal average images of the 4D-CTAwas
presented to the observers (method 1). In a second step, dynamic
subtraction rendering of 4D-CTA was available in addition to
color-mapping (method 2).
The primary outcome measure was the detection of cranial
AVFs. In case an AVF or CCF was identified, the location, domi-
nant arterial feeders, and the pattern of venous drainage were
assessed. The secondary outcome measure was the presence or
absence of cortical venous reflux, which is of relevance for grading
the dural AVF and for treatment decision-making.10 The CCFs
were graded as either direct type (originating from the internal
carotid artery) or indirect type (branches of the external carotid
artery serving as arterial feeders).
Reference Standard and Statistical Analysis
DSAwas performed in the clinical diagnostic work-up of all cases,
was independently evaluated by neurovascular interventionalists,
and served as the reference standard for the primary and second-
ary outcome measures. Measures of diagnostic accuracy for the
detection of AVFs on 4D-CTA color-mappingwere calculated per
observer. Fleiss 	 statistics11 was used for assessing agreement for
AVF detection among the 3 observers. The Krippendorff statisti-
cal test12 was used for evaluating interobserver agreement on cor-
tical venous reflux (taking possible missing data points into ac-
count). SPSS Statistics (Version 25; IBM, Armonk, New York)
and Python 3.6were used for datamanagement and data analyses.
RESULTS
Study Population
A total of 34 patients were included, of whom3were excluded due
to failure of the vessel segmentation. The failure was the result of
heavy distortion due to metal artifacts and poor contrast opacifi-
cation of the vasculature. The remaining study population con-
sisted of 31 patients, 21 with and 10 without a cranial AVF. The
group of AVFs consisted of 18 dural AVFs and 3 CCFs. An over-
view of the study population demographics and AVF characteris-
tics is provided in Table 1.
Diagnostic Accuracy
The results of the color-mapping evaluation of 4D-CTA per ob-
server are provided in Table 2. Overall, there was high sensitivity
(86%–100%) and moderate-to-high specificity (70%–100%) for
the detection of cranial AVFs on color-mapping 4D-CTA. For
Table 1: Patient demographics and characteristics of the AVFs
Cranial AVF
Present
(n = 21)
Cranial AVF
Absent
(n = 10)
Sex (male/female) 13:8 3:7
Mean age (SD) (yr) 62 (12) 51 (14)
Presenting with pulsatile tinnitus (No.) 8 7
Mean time to DSA (SD) (day) 49 (68) 179 (205)
Dural AVF location (No.)
Dural sinus 9 –
Posterior fossa 5 –
Anterior skull base 2 –
Supratentorial convexity 2 –
Dural AVF classification (No.)
Borden type I 9 –
Borden type II 3 –
Borden type III 6 –
CCF
Direct type 1 –
Indirect type 2 –
Note:—– indicates no data.
Table 2: Diagnostic accuracy of the 3 observers for the detection of cranial AVFs (n 31), with DSA serving as the reference standarda
Detection of AVF
Observer 1,
Method 1b
Observer 2,
Method 1b
Observer 3,
Method 1b
Observer 1,
Method 2c
Observer 2,
Method 2c
Observer 3,
Method 2c
True-positive, true-negative 19 10 21 10 18 7 20 10 21 10 18 7
False-positive, false-negative 0 2 0 0 3 3 0 1 0 0 3 3
Sensitivity (%) (95% CI) 90 (70–99) 100 (81–100) 86 (63–96) 95 (76–100) 100 (81–100) 86 (63–96)
Specificity (%) (95% CI) 100 (69–100) 100 (66–100) 70 (35–92) 100 (69–100) 100 (66–100) 70 (35–92)
PPV (%) (95% CI) 100 (80–100) 100 (81–100) 86 (63–96) 100 (80–100) 100 (81–100) 86 (63–96)
NPV (%) (95% CI) 83 (57–94) 100 (66–100) 70 (35–92) 91 (60–98) 100 (66–100) 70 (35–92)
Fleiss 	 0.619 (Substantial agreement) 0.661 (Substantial agreement)
Note:—PPV indicates positive predictive value; NPV, negative predictive value.
a The Fleiss 	 for interobserver agreement is shown per method.
b Method 1, color-mapping only.
c Method 2, color-mapping and dynamic subtraction rendering of 4D-CTA.
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observer 1, two cases were rated false-negative on 4D-CTA color-
mapping, of which 1 (a CCF) was detected with additional dy-
namic subtraction rendering. All AVFs were correctly identified
on 4D-CTA color-mapping by observer 2, even before the avail-
ability of dynamic subtraction rendering. For observer 3, three
cases were read as false-negative and 3 cases were read as false-
positive. For observers 2 and 3, there were no changes in the read-
ing before and after the availability of dynamic subtraction ren-
dering. In all cases with a true-positive evaluation of 4D-CTA,
therewas full agreementwithDSA for the location of the AVFs for
all observers. The interobserver agreement for the detection of
cranial AVFs was substantial (0.619 for method 1 and 0.661 for
method 2).
The diagnostic performance in the detection of cortical ve-
nous reflux was highly variable among the observers (Table 3),
ranging from low-to-high sensitivity (43%–88%) and moder-
ate specificity (60%–80%) for both methods. Only for ob-
server 3 was there a slight increase in sensitivity with the avail-
ability of dynamic subtraction rendering because cortical
venous reflux was correctly identified in 1 additional case (ini-
tial false-negative reading on color-mapping). Regarding the 3
cases with a CCF included in the evaluation, 1 case with an
indirect type of CCF was, as mentioned, initially missed on
color-mapping by observer 1 but was detected with the avail-
ability of dynamic subtraction rendering. This case was de-
tected by observers 2 and 3 but was misclassified as a direct type
by observer 2 and could not be classified by observer 3. The
interobserver agreement for the detection of cortical venous
reflux was fair (0.294 for method 1 and 0.372 for method 2).
DISCUSSION
We have presented a visualization technique to represent temporal
information of the cerebral vasculature in a 4D-CTA acquisition,
enabling accurate detection and enhanced visualization of cranial
AVFs. The visualization of contrast bolus arrival times using a color
scale enables temporal information (4D) to be assessed on a 3D vol-
ume without losing information. The 3 observers were able to accu-
rately detect and localize the AVFs using 4D-CTA color-mapping,
even without the availability of dynamic subtraction rendering. The
difference in the diagnostic performance among the observers is
most likely related to the level of experience in reading4D-CTAstud-
ies and is a reflection of clinical practice. Examples of AVFs in differ-
ent locations as detected on 4D-CTA color-mapping are provided in
Figs 2–4.
The detection of cortical venous reflux on 4D-CTA color-map-
ping, with the availability of dynamic subtraction rendering, proved
FIG 2. Left image, 4D-CTA color-mapping in a patient with a dural AVF located in the left sigmoid sinus. Early contrast bolus arrival and
arterialization of the left sigmoid sinus are depicted in red (large arrow). Middle image, 3D rendering of color-mapping. Right image, conven-
tional angiography. Note the occipital artery branches serving as arterial feeders (small arrows) with anterograde venous drainage in the jugular
vein.
Table 3: Diagnostic accuracy for the detection of cortical venous reflux on 4D-CTA for the correctly identified AVFs by the 3 observers,
with DSA serving as the reference standarda
Cortical Venous Reflux
Observer 1,
Method 1
(n = 16)b
Observer 2,
Method 1
(n = 18)b
Observer 3,
Method 1
(n = 15)b
Observer 1,
Method 2
(n = 17)c
Observer 2,
Method 2
(n = 18)c
Observer 3,
Method 2
(n = 15)c
True-positive,
true-negative
6 6 7 8 3 5 6 6 7 8 4 5
False-positive,
false-negative
3 1 2 1 3 4 4 1 2 1 3 3
Sensitivity (%) (95% CI) 86 (42–100) 88 (47–100) 43 (10–82) 86 (42–100) 88 (47–100) 57 (18–90)
Specificity (%) (95% CI) 67 (30–93) 80 (44–97) 63 (25–92) 60 (26–88) 80 (44–97) 63 (24–91)
PPV (%) (95% CI) 67 (43–84) 78 (50–93) 50 (23–78) 60 (40–77) 78 (50–93) 57 (31–80)
NPV (%) (95% CI) 86 (48–98) 89 (55–98) 56 (35–74) 86 (48–98) 89 (55–98) 63 (32–84)
Krippendorff  0.294 (Fair agreement) 0.372 (Fair agreement)
Note:—PPV indicates positive predictive value; NPV, negative predictive value.
a The Krippendorff  for interobserver agreement is shown per method.
b Method 1, color-mapping only.
c Method 2, color-mapping and dynamic subtraction rendering of 4D-CTA.
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challenging. The performance in the detection of cortical venous re-
fluxwas probably also related to the observers’ experience in reading
4D-CTA because observers 1 and 2 were considerably more experi-
enced in reading4D-CTAthanobserver3.Cortical venous refluxcan
be depicted on 4D-CTA, as has been reported previously1,13, but
therewerediscrepancieswithDSAinaconsiderablenumberof cases.
Although our study population was scanned with a continuous 4D-
CTAvolumeacquisition, the temporal resolutionwas set at 1volume
per second based on which color-mapping was applied. A higher
temporal resolutionwould enable targeted color-mapping in amore
specific timeframe during the acquisition, which could improve the
evaluation of cortical venous reflux.
The cerebral vessel segmentation is an important part of the
presented method. It allows the arrival times to be extracted di-
rectly from the vascular system, and it reduces the large amount of
4D-CTA data to the essential parts needed for the diagnostic eval-
uation and visualization of the cerebral vasculature hemodynam-
ics. The accuracy of the color-mapping method is therefore
strongly dependent on the quality of the vessel segmentation,
which is especially challenging for small-caliber arteries and veins.
When combined with vessel labeling, this method could serve as a
base for automated detection of AVFs.
Three patients were excluded due to failed color-mapping,
which resulted from insufficient vessel segmentation. Although
only 3 patients were excluded, it is a relatively large percentage of
the small dataset. The vessel segmentation algorithm was primar-
ily developed for a discontinuous 4D-CTA scanning protocol
used in acute ischemic stroke.9 This feature may cause the vessel-
segmentation algorithm to be less equipped to handle image arti-
facts and suboptimal contrast opacification of the vasculature. A
vessel segmentation algorithm optimized for a continuous 4D-
CTA scanning protocol might result in a decreased failure rate of
the vessel segmentations.
The  factor in the TTS calculation of the presented method
defines the threshold for the contrast bolus arrival time in the
cerebral vasculature and determines the final visualization. A low
 factor is more suited to a detailed distinction in early contrast-
arrival times, making it more sensitive for the detection of arteri-
alized venous structures (ie, arteriovenous shunts). In other pa-
thologies such as ischemic stroke, a higher  factor resembles the
time-to-peak, which is beneficial for the evaluation of the collat-
eral vessel status, which is an important independent predictor of
patient outcome.14 Preliminary results already showed that the
temporal dynamics of collateral flow in the circle of Willis can be
FIG 3. Left image, 4D-CTA color-mapping in a patient with a small dural AVF located at the left anterior skull base. Middle image, 3D
rendering of color-mapping. Right image, conventional angiography. Early contrast bolus arrival of the AVF is seen as a prominent red
(arrow). The ophthalmic artery with ethmoidal branches serving as the arterial feeder and arterialization of a tortuous cortical draining
vein are clearly seen.
FIG 4. Left image, 4D-CTA color-mapping of 4D-CTA in a patient with a dural AVF located in the left condylar venous plexus (white arrow).
Middle image, 3D rendering of the color-mapping. Right image, conventional angiography. The ascending pharyngeal artery serves as the feeding
artery (black arrow), and venous drainage is into the green jugular vein.
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depicted in patients with a unilateral carotid artery occlusion us-
ing the presented method.15 It is expected that color-mapping
could also be beneficial for 4D-CTA evaluation of vascular mal-
formations in other organ systems or in the evaluation of cardio-
vascular pathology. The visualization of arrival times using a color
scale has been suggested before in 2D-DSA16-18 and in 4D-
CTA,19,20 but none of thesemethods are adjusted for each patient
individually independent from the cerebral blood flow, heart rate,
and cardiac output function. The application of a histogram to
normalize the arrival times for each patient individually is a novel
approach that allows an automatic visualization and comparison
among patients with different contrast bolus arrival times. The
20% threshold on the TTS histogram was chosen to ensure the
detection of the contrast bolus arrival at a reasonable signal-to-
noise ratio. Relevant arrival times in other parts of the vasculature
that might be outside the flow window are still visualized as the
flow-window servers as anchor points the color scale and no ar-
rival times are masked out.
Our study has some limitations. First, our study population
was collected retrospectively with the risk of selection bias. Our
findings therefore need validation in a prospective cohort
study. Second, dynamic subtraction rendering of 4D-CTA was
not independently evaluated from color-mapping because we
chose to evaluate color-mapping in a manner similar to that
applied in clinical practice in which both color-mapping and
dynamic subtraction rendering are available. Our goal was not
to repeal dynamic subtraction rendering of 4D-CTA but to
provide color-mapping as an initial evaluation tool of 4D-
CTA, enabling accurate detection of an AVF, with dynamic
subtraction rendering available for further detailed analysis.
However, a direct comparison is of added value, which can be
evaluated in a future prospective study. Third, the role of 4D-
CTA in the diagnostic work-up of AVFs is still under debate,
and a direct comparison of the diagnostic accuracy of 4D-CTA
with DSA or time-resolved MR angiography is lacking. MR
angiography is preferable to 4D-CTA because the patient is not
exposed to radiation. On the contrary, 4D-CTA is preferable to
dynamic MR angiography because 4D-CTA is much less lim-
ited by the trade-off between temporal and spatial resolu-
tion.21 In addition, the radiation dose of 4D-CTA is currently
considerably reduced by advanced noise filtering and registra-
tion techniques, though this reduction still strongly depends
on the exact scanning protocol. Last, we did not include sub-
jects with intracranial AVMs in our cohort to have a more
homogeneous study population. It is expected that AVMs can
also be detected with high accuracy using 4D-CTA color-map-
ping because an AVM is also characterized by AV shunting.
Nevertheless, a follow-up study is needed to validate this
assumption.
CONCLUSIONS
Arterialization of venous structures is visualized by color-map-
ping of 4D-CTA and proves to be accurate for the detection of
cranial AVFs. This finding makes color-mapping a promising vi-
sualization technique for 4D-CTA.
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